How Analysts Rated Avinger, Inc. (NASDAQ:AVGR) Last Week?

January 15, 2018 - By Marguerite Chambers

 How Analysts Rated Avinger, Inc. (NASDAQ:AVGR) Last Week?

Avinger, Inc. (NASDAQ:AVGR) Ratings Coverage

Among 3 analysts covering Avinger (NASDAQ:AVGR), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Avinger had 3 analyst reports since December 29, 2015 according to SRatingsIntel. The stock of Avinger, Inc. (NASDAQ:AVGR) earned “Neutral” rating by Dougherty & Company on Tuesday, December 29. Canaccord Genuity downgraded it to “Hold” rating and $1 target in Tuesday, April 11 report. The stock of Avinger, Inc. (NASDAQ:AVGR) earned “Perform” rating by Oppenheimer on Wednesday, April 12. Below is a list of Avinger, Inc. (NASDAQ:AVGR) latest ratings and price target changes.

The stock decreased 4.88% or $0.01 during the last trading session, reaching $0.195. About 609,440 shares traded. Avinger, Inc. (NASDAQ:AVGR) has declined 96.51% since January 15, 2017 and is downtrending. It has underperformed by 113.21% the S&P500.

Avinger, Inc., a commercial-stage medical device company, designs, makes, and sells image-guided and catheter systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company has market cap of $6.40 million. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. It currently has negative earnings. The companyÂ’s lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients.

More recent Avinger, Inc. (NASDAQ:AVGR) news were published by: Streetinsider.com which released: “Avinger (AVGR) Reports 510(k) Filing of Next Generation Pantheris Device” on December 21, 2017. Also Globenewswire.com published the news titled: “Avinger Receives CE Marking Approval for Next Generation Pantheris Image …” on December 20, 2017. Globenewswire.com‘s news article titled: “Avinger Announces Treatment of First Patients Globally With Next Generation …” with publication date: January 03, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.